Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 30Anemia, Refractory, with Excess of Blasts 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Myelodysplastic Syndromes 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 19Multiple Myeloma 16Hodgkin Disease 16Anemia, Aplastic 16Lymphoma, Non-Hodgkin 15Leukemia, Lymphocytic, Chronic, B-Cell 15Myeloproliferative Disorders 12Lymphoma 11Primary Myelofibrosis 10Hematologic Neoplasms 10Leukemia 9Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelomonocytic, Chronic 5Polycythemia Vera 4Immunologic Deficiency Syndromes 4Hemoglobinopathies 4Fanconi Anemia 4Burkitt Lymphoma 4Blast Crisis 4Anemia, Sickle Cell 4Anemia, Refractory 4Anemia 4Thalassemia 3Recurrence 3

Interventions

Thiotepa 3Melphalan 3Cyclophosphamide 3fludarabine phosphate 2fludarabine 2Busulfan 2Alemtuzumab 2Whole-Body Irradiation 1Tacrolimus 1Muromonab-CD3 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Immunotherapy 1Drug Therapy 1Antilymphocyte Serum 1Antibodies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Histiocytosis × fludarabine × Classical hematology × Clear all
NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

NCT00145626 2017-06-19

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Completed
40 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡